CryoLife develops and commercializes technology for cryo-preservation of viable human cardiovascular and orthopedic tissues for transplant. The company uses proprietary processes to disinfect, preserve, store, and transport human heart valves, veins, and tissues used in cardiac, vascular, and orthopedic surgeries. Tissues preserved using the company's cryogenic processes can be stored for extended periods while retaining viability for human implantation. The company is based in Kennesaw, Georgia.